Publication | Closed Access

Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the nishinihon cooperative study group of adjuvant chemoendocrine therapy for breast cancer (ACETBC) of Japan

Breast OncologyOncologyAdjuvant Chemoendocrine TherapyBreast CancerPostoperative AdjuvantBreast SurgeryMedicineRadiation Oncology